Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Wagenblast

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Anticancer Research|May 30, 2008
Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell linesJens Wagenblast, Markus Hambek, Mehran Baghi, et al.
Oncology Letters|November 20, 2012
Small molecules in combination with conventional chemotherapeutic drugs: Light at the end of the tunnel?Martin Leinung, Clemens Cuny, Marc Diensthuber, et al.
Neuroreport|August 5, 2014
Clonal colony formation from spiral ganglion stem cellsMarc Diensthuber, Veronika Zecha, Jens Wagenblast, et al.
Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]|February 12, 2011
Tenth and twelfth nerve palsies in a patient with internal carotid artery dissection mistaken for cervical mass lesionChristoph Arnoldner, Dominik Riss, Jens Wagenblast, et al.
Anticancer Research|March 14, 2013
The role of p16 expression as a predictive marker in HPV-positive oral SCCHN--a retrospective single-center studyChristin Geißler, Aykut Tahtali, Marc Diensthuber, et al.
Acta Oto-Laryngologica|January 14, 2009
A new electrode for residual hearing preservation in cochlear implantation: first clinical resultsWolfgang Gstoettner, Silke Helbig, Claudia Settevendemie, et al.
Anticancer Research|June 3, 2006
A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN)Mehran Baghi, Markus Hambek, Jens Wagenblast, et al.
Head & Neck|November 24, 2006
Inverse correlation between serum PGE2 and T classification in head and neck cancerMarkus Hambek, Mehran Baghi, Jens Wagenblast, et al.
Oncology Letters|December 11, 2012
Fighting cancer from different signalling pathways: Effects of the proteasome inhibitor Bortezomib in combination with the polo-like-kinase-1-inhibitor BI2536 in SCCHNMartin Leinung, Daniel Hirth, Aykut Tahtali, et al.
Oncology Letters|July 19, 2012
Effects of the Polo-like-kinase-1-inhibitor BI2536 in squamous cell carcinoma cell lines of the head and neckJens Wagenblast, Daniel Hirth, Laura Thron, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Anticancer Research|May 30, 2008
Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell linesJens Wagenblast, Markus Hambek, Mehran Baghi, et al.
Oncology Letters|November 20, 2012
Small molecules in combination with conventional chemotherapeutic drugs: Light at the end of the tunnel?Martin Leinung, Clemens Cuny, Marc Diensthuber, et al.
Neuroreport|August 5, 2014
Clonal colony formation from spiral ganglion stem cellsMarc Diensthuber, Veronika Zecha, Jens Wagenblast, et al.
Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]|February 12, 2011
Tenth and twelfth nerve palsies in a patient with internal carotid artery dissection mistaken for cervical mass lesionChristoph Arnoldner, Dominik Riss, Jens Wagenblast, et al.
Anticancer Research|March 14, 2013
The role of p16 expression as a predictive marker in HPV-positive oral SCCHN--a retrospective single-center studyChristin Geißler, Aykut Tahtali, Marc Diensthuber, et al.
Acta Oto-Laryngologica|January 14, 2009
A new electrode for residual hearing preservation in cochlear implantation: first clinical resultsWolfgang Gstoettner, Silke Helbig, Claudia Settevendemie, et al.
Anticancer Research|June 3, 2006
A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN)Mehran Baghi, Markus Hambek, Jens Wagenblast, et al.
Head & Neck|November 24, 2006
Inverse correlation between serum PGE2 and T classification in head and neck cancerMarkus Hambek, Mehran Baghi, Jens Wagenblast, et al.
Oncology Letters|December 11, 2012
Fighting cancer from different signalling pathways: Effects of the proteasome inhibitor Bortezomib in combination with the polo-like-kinase-1-inhibitor BI2536 in SCCHNMartin Leinung, Daniel Hirth, Aykut Tahtali, et al.
Oncology Letters|July 19, 2012
Effects of the Polo-like-kinase-1-inhibitor BI2536 in squamous cell carcinoma cell lines of the head and neckJens Wagenblast, Daniel Hirth, Laura Thron, et al.
Pageof 5